Dr. Craig Brown, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 720 W Corbett Ave, Swansboro, NC 28584 Phone: 910-326-3611 |
Dr. Teresa Gail Conley, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1306 W Corbett Ave, Swansboro, NC 28584 Phone: 910-326-2030 Fax: 910-326-3192 |
Dr. Gina C Mancini, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 718 A West Corbett Avenue, Swansboro, NC 28584 Phone: 910-326-3611 Fax: 910-326-1122 |
Dr. Doris J Black, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 200 718a West Corbett Avenue, Swansboro, NC 28584 Phone: 910-326-3611 Fax: 910-326-1122 |
Dr. Fred H Miller, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 718a W Corbett Ave, Swansboro, NC 28584 Phone: 910-326-3611 Fax: 910-326-1122 |
News Archive
Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs, announced today the successful results of the company's Phase IIb pivotal study of P2B001 for the treatment of early stage Parkinson's Disease (PD).
Dozens of states are passing or debating new restrictions on abortion, a trend fueled in part by passage of the nation's new health care law. Both sides of the hot-button issue are seeing new approaches to reduce abortions. … So far, 2010 has been 'very successful,' said Mary Spaulding Balch of the National Right to Life Committee.
ACR Image Metrix™, an imaging contract research organization (CRO) with expertise in imaging research design, techniques and data extraction, congratulates their partner, iCAD, Inc., on obtaining U.S. Food and Drug Administration clearance on its VeraLook™, Colon CAD (Computer-Aided Detection) software.
PsiOxus Therapeutics, Ltd., a development stage biotechnology company, today announced the award of a £1.7 million ($2.7 million) grant from the UK government-backed Biomedical Catalyst to initiate a Phase I/II clinical trial to assess the use of ColoAd1 in the treatment of platinum-resistant, recurrent ovarian cancer.
› Verified 9 days ago